NYSE:HNGR

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. More Details


Snowflake Analysis

Solid track record and fair value.


Similar Companies

Share Price & News

How has Hanger's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: HNGR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: HNGR's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

1.7%

HNGR

0.1%

US Healthcare

-2.5%

US Market


1 Year Return

-3.7%

HNGR

20.9%

US Healthcare

34.1%

US Market

Return vs Industry: HNGR underperformed the US Healthcare industry which returned 20.9% over the past year.

Return vs Market: HNGR underperformed the US Market which returned 34.1% over the past year.


Shareholder returns

HNGRIndustryMarket
7 Day1.7%0.1%-2.5%
30 Day-2.1%-3.8%0.1%
90 Day-3.1%3.6%4.5%
1 Year-3.7%-3.7%22.5%20.9%37.1%34.1%
3 Year50.5%50.5%34.9%29.3%58.0%47.9%
5 Year621.2%621.2%79.7%66.3%131.9%106.2%

Long-Term Price Volatility Vs. Market

How volatile is Hanger's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Hanger undervalued compared to its fair value and its price relative to the market?

20.72x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: HNGR ($21.31) is trading above our estimate of fair value ($4.89)

Significantly Below Fair Value: HNGR is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: HNGR is good value based on its PE Ratio (19.7x) compared to the US Healthcare industry average (26.2x).

PE vs Market: HNGR is good value based on its PE Ratio (19.7x) compared to the US market (21.5x).


Price to Earnings Growth Ratio

PEG Ratio: HNGR is good value based on its PEG Ratio (0.6x)


Price to Book Ratio

PB vs Industry: HNGR is overvalued based on its PB Ratio (25.2x) compared to the US Healthcare industry average (3.5x).


Next Steps

Future Growth

How is Hanger forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

33.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HNGR's forecast earnings growth (33.9% per year) is above the savings rate (2%).

Earnings vs Market: HNGR's earnings (33.9% per year) are forecast to grow faster than the US market (20.4% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HNGR's revenue (9.4% per year) is forecast to grow slower than the US market (10.5% per year).

High Growth Revenue: HNGR's revenue (9.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if HNGR's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Hanger performed over the past 5 years?

95.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HNGR has high quality earnings.

Growing Profit Margin: HNGR's current net profit margins (4%) are higher than last year (1.2%).


Past Earnings Growth Analysis

Earnings Trend: HNGR has become profitable over the past 5 years, growing earnings by 95.8% per year.

Accelerating Growth: HNGR's earnings growth over the past year (205.2%) exceeds its 5-year average (95.8% per year).

Earnings vs Industry: HNGR earnings growth over the past year (205.2%) exceeded the Healthcare industry 16%.


Return on Equity

High ROE: Whilst HNGR's Return on Equity (126.53%) is outstanding, this metric is skewed due to their high level of debt.


Next Steps

Financial Health

How is Hanger's financial position?


Financial Position Analysis

Short Term Liabilities: HNGR's short term assets ($363.5M) exceed its short term liabilities ($260.3M).

Long Term Liabilities: HNGR's short term assets ($363.5M) do not cover its long term liabilities ($660.1M).


Debt to Equity History and Analysis

Debt Level: HNGR's debt to equity ratio (1603%) is considered high.

Reducing Debt: HNGR's debt to equity ratio has increased from 228.6% to 1603% over the past 5 years.

Debt Coverage: HNGR's debt is well covered by operating cash flow (31.7%).

Interest Coverage: HNGR's interest payments on its debt are not well covered by EBIT (2.3x coverage).


Balance Sheet


Next Steps

Dividend

What is Hanger current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate HNGR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HNGR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HNGR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HNGR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HNGR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.8yrs

Average management tenure


CEO

Vinit Asar (54 yo)

8.75yrs

Tenure

US$4,940,254

Compensation

Mr. Vinit K. Asar has been the Chief Executive Officer and President of Hanger Orthopedic Group Inc. (known as Hanger, Inc.) since May 21, 2012 and September 12, 2011 respectively. Mr. Asar served as the P...


CEO Compensation Analysis

Compensation vs Market: Vinit's total compensation ($USD4.94M) is above average for companies of similar size in the US market ($USD2.21M).

Compensation vs Earnings: Vinit's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Vinit Asar
CEO, President & Director8.75yrsUS$4.94m2.09%
$ 17.0m
Thomas Kiraly
CFO & Executive VP6.08yrsUS$1.57m0.72%
$ 5.9m
C. Ranson
Executive VP of Corporate Services & Chief Information Officer5.58yrsUS$826.16k0.23%
$ 1.9m
Thomas Hartman
Senior VP11.67yrsUS$1.10m0.29%
$ 2.3m
Gabrielle Adams
VP & Chief Accounting Officer3.83yrsno data0.16%
$ 1.3m
Paul Severt
VP of Corporate Finance & Treasurer5.75yrsno datano data
Seth Frank
Vice President of Treasury & Investor Relations3.08yrsno datano data
Mitchell Dobson
Senior VP & Chief Compliance Officer2.33yrsno data0.085%
$ 689.6k
Krisita Burket
Vice President of Public Relations & Communicationsno datano datano data
Keri Jolly
Senior VP & Chief Human Resources Officer2.58yrsno data0.076%
$ 615.4k
James Campbell
Senior VP & Chief Clinical Officer2.33yrsno data0.11%
$ 879.6k
Regina Weger
President of Products & Services1.17yrsno data0.047%
$ 378.4k

3.8yrs

Average Tenure

54yo

Average Age

Experienced Management: HNGR's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Vinit Asar
CEO, President & Director8.75yrsUS$4.94m2.09%
$ 17.0m
Stephen Hare
Independent Director10.75yrsUS$240.01k0.12%
$ 935.3k
Christopher Begley
Independent Non-Executive Chairman3.08yrsUS$335.01k0.16%
$ 1.3m
Thomas Freyman
Independent Director3.25yrsUS$245.01k0.040%
$ 322.8k
Thomas Cooper
Director Emeritus3.08yrsno datano data
Richard Pettingill
Independent Director7yrsUS$235.01k0.16%
$ 1.3m
Kathryn Sullivan
Independent Director6.08yrsUS$225.01k0.12%
$ 993.7k
Cynthia Lucchese
Independent Director5.75yrsUS$225.01k0.14%
$ 1.1m
John Fox
Independent Director3.25yrsUS$225.01k0.034%
$ 277.4k
Asif Ahmad
Independent Director6.5yrsUS$225.01k0.15%
$ 1.2m
Mark Jones
Director0.42yrno datano data

5.8yrs

Average Tenure

66yo

Average Age

Experienced Board: HNGR's board of directors are considered experienced (5.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.1%.


Top Shareholders

Company Information

Hanger, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Hanger, Inc.
  • Ticker: HNGR
  • Exchange: NYSE
  • Founded: 1861
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: US$812.111m
  • Shares outstanding: 38.11m
  • Website: https://www.hanger.com

Number of Employees


Location

  • Hanger, Inc.
  • 10910 Domain Drive
  • Suite 300
  • Austin
  • Texas
  • 78758
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HNGRNYSE (New York Stock Exchange)YesCommon SharesUSUSDFeb 1986

Biography

Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/02/24 23:18
End of Day Share Price2021/02/24 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.